Disappointing Results For Statins In Two NIH Trials

May 18, 2014 7:11 PM

19 0

Two NHLBI studies have failed to find any benefit for statin therapy in patients with chronic obstructive pulmonary disease (COPD) and acute respiratory distress syndrome (ARDS). Previous observational studies had raised the possibility that statins, perhaps due to their anti-inflammatory effects, might improve outcomes in people with these serious diseases. But both trials were stopped early by their data and safety monitoring boards for futility. The results of the trials were presented at the annual meeting of the American Thoracic Society and published simultaneously in the New England Journal of Medicine.

STATCOPE (Prospective Randomized Placebo-Controlled Trial of Simvastatin in the Prevention of COPD Exacerbations) randomized 885 patients with COPD to either simvastatin or placebo; patients taking or requiring statins were excluded. After 641 days of follow-up, there was no significant difference i...

Read more

To category page